Phase II trial of AVN-101 for treatment of Alzheimer's disease.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2010
At a glance
- Drugs AVN 101 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 01 Jan 2010 Status changed from planning to recruiting, as reported in an Avineuro Pharmaceuticals media release.
- 09 Apr 2009 New trial record.